{
    "paper_id": "9d996afb253fa3ee05145213a3decfd82db5b57d",
    "metadata": {
        "title": "Diabetes and COVID-19: The potential role of mTOR",
        "authors": [
            {
                "first": "B",
                "middle": [],
                "last": "Pinchera",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "R",
                "middle": [],
                "last": "Scotto",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "A",
                "middle": [
                    "R"
                ],
                "last": "Buonomo",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "E",
                "middle": [],
                "last": "Zappulo",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "F",
                "middle": [],
                "last": "Stagnaro",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "A",
                "middle": [],
                "last": "Gallicchio",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "G",
                "middle": [],
                "last": "Viceconte",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "A",
                "middle": [],
                "last": "Sardanelli",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "S",
                "middle": [],
                "last": "Mercinelli",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "R",
                "middle": [],
                "last": "Villari",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "M",
                "middle": [],
                "last": "Foggia",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "I",
                "middle": [],
                "last": "Gentile",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Federico",
                "middle": [],
                "last": "Ii",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Covid",
                "middle": [],
                "last": "Team",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "mTOR (mammalian Target Of Rapamycin) is a crucial pathway in many physiological processes, such as cell cycle progression, transcription, translation, differentiation, apoptosis, motility and cell metabolism. mTOR plays a central role in the regulation of cell growth and proliferation, at the translational level, and in cell cycle progression, in particular, mTOR also modulates protein synthesis through regulation of RNA polymerases I and III, which are responsible for ribosomal and transfer RNA transcription (Fig. 1) . It is known that the mTOR pathway plays a fundamental role in viral translation [1] . It is already known that several viruses such as Adenovirus, Cytomegalovirus, Herpesvirus and the same Middle Eastern Respiratory Syndrome Coronavirus (MERS -CoV) use the mTOR pathway to be able to replicate [2, 3] . In particular, the mTOR pathway also appears to be involved in the life cycle of SARS-CoV-2 infection [4] . The antiviral properties of mTORis have been known and ascribed to a variety of mechanisms [5] .",
            "cite_spans": [
                {
                    "start": 606,
                    "end": 609,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 820,
                    "end": 823,
                    "text": "[2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 824,
                    "end": 826,
                    "text": "3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 931,
                    "end": 934,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1028,
                    "end": 1031,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [
                {
                    "start": 515,
                    "end": 523,
                    "text": "(Fig. 1)",
                    "ref_id": null
                }
            ],
            "section": "mTOR pathway and COVID-19"
        },
        {
            "text": "Blockade of the mTOR pathway induces an inhibition of protein synthesis and prevents the activation of lymphocytes [6, 7] . Furthermore, it inhibits the expression of proinflammatory cytokines, such as IL-2, IL-6 and IL-10 and suppresses the cytokine storm [2] . These data were observed with the use of rapamycin, an inhibitor of the mTOR pathway. In particular, rapamycin is able to interrupt the cell cycle of T cells during their transition from G1 to S phase by inhibiting signalmediated interleukin [8] [9] [10] [11] . The authors Husain and Byrareddy evaluated the different uses of Rapamycin, highlighting that this drug with its action can help control the synthesis of viral particles, cytokine storms and helps fight the disease thanks to its anti-aging effects [4] . Maiese et al. showed that mTOR pathways in combination with AMPK (Adenosine Monophosphate-activated Protein Kinase) may offer valuable targets for controlling cell damage, oxidative stress, mitochondrial dysfunction and the onset of hyperinflammation, a significant dysregulation associated with COVID-19 [5] . mTOR inhibitors in preventing COVID-19 severity were examined in an article by Zheng the potential role of these drugs in reducing the possible development of the dysregulated inflammatory process was shown and therefore their possible role in preventing severe forms of disease was hypothesized [12] . This hypothesis was based on the ability of mTOR inhibitors to limit the proliferation of memory B cells and T cell responses [10] . Ramaiah et al. showed a potential action of rapamycin in inhibiting SARS-CoV-2 infection and replication in human lung cells [13, 14] . Sargiacomo et al. evaluated the use of azithromycin, doxycycline and rapamycin, drugs that inhibit protein synthesis, demonstrating that these drugs reduced inflammation and viral replication. Mechanistically, this is due to the fact that cytokines and viruses are both made up of proteins. Both use cellular ribosomes for protein translation [15] .",
            "cite_spans": [
                {
                    "start": 115,
                    "end": 118,
                    "text": "[6,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 119,
                    "end": 121,
                    "text": "7]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 257,
                    "end": 260,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 505,
                    "end": 508,
                    "text": "[8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 509,
                    "end": 512,
                    "text": "[9]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 513,
                    "end": 517,
                    "text": "[10]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 518,
                    "end": 522,
                    "text": "[11]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 773,
                    "end": 776,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 779,
                    "end": 792,
                    "text": "Maiese et al.",
                    "ref_id": null
                },
                {
                    "start": 1084,
                    "end": 1087,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1169,
                    "end": 1174,
                    "text": "Zheng",
                    "ref_id": null
                },
                {
                    "start": 1386,
                    "end": 1390,
                    "text": "[12]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1519,
                    "end": 1523,
                    "text": "[10]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 1651,
                    "end": 1655,
                    "text": "[13,",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 1656,
                    "end": 1659,
                    "text": "14]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 2005,
                    "end": 2009,
                    "text": "[15]",
                    "ref_id": "BIBREF15"
                }
            ],
            "ref_spans": [],
            "section": "mTOR pathway and COVID-19"
        },
        {
            "text": "The inhibitory action on the mTOR pathway can help control the synthesis of viral particles and regulate cytokine storms [16] [17] [18] . mTOR inhibitors also suppress early B cell production and reduce antigenspecific memory B cell populations. Therefore, SARS-CoV-2 infected patients treated with mTOR inhibitors can be expected to have reduced early cross-reactive antibody production and thus less antibodydependent enhancement. Therefore, mTOR inhibitors could act as a double-edged sword in COVID-19 patients [19, 20] .",
            "cite_spans": [
                {
                    "start": 121,
                    "end": 125,
                    "text": "[16]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 126,
                    "end": 130,
                    "text": "[17]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 131,
                    "end": 135,
                    "text": "[18]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 515,
                    "end": 519,
                    "text": "[19,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 520,
                    "end": 523,
                    "text": "20]",
                    "ref_id": "BIBREF20"
                }
            ],
            "ref_spans": [],
            "section": "mTOR pathway and COVID-19"
        },
        {
            "text": "From the various studies reported it emerges that the inhibitory drugs of the mTOR pathway, through the regulation of T cells, the reduction of viral replication and the reduction of the production of proinflammatory cytokines, would seem to be able to play a role in the regulation and management of that inflammatory process [21] .",
            "cite_spans": [
                {
                    "start": 327,
                    "end": 331,
                    "text": "[21]",
                    "ref_id": "BIBREF21"
                }
            ],
            "ref_spans": [],
            "section": "mTOR pathway and COVID-19"
        },
        {
            "text": "It is well known that patients suffering from COVID-19 (CoronaVIrus Disease-19 (COVID-19) with diabetes have a poorer prognosis than patients without diabetes. In fact, the disease is more severe and the mortality rate higher in patient with diabetes than in those without [22] [23] [24] [25] . In addition hyperglycemia, regardless of the diagnosis of diabetes, has been implicated in a poor prognosis in patients with COVID-19 [26, 27] . A prevalence of about 10% of diabetes has been reported in patients with COVID-19, thereby constituting the most frequent comorbidity [28] [29] [30] . Moreover, this prevalence fluctuated between 7% and 21% [10] . The prevalence of diabetes in COVID-19 patients varied widely depending on the geographic areas considered [31, 32] . Additionally, patients with diabetes and COVID-19 have an approximately three times greater relative risk of developing serious disease and a higher mortality rate than patients with COVID-19 and without diabetes. [33] [34] [35] [36] [37] [38] . Several studies compared COVID-19 patients with diabetes to those without. A retrospective observational study from 88 US hospitals (n = 570), showed a significant increase in death rate in patients with diabetes compared to those without (28.8% versus 6.2%, p < 0.001) [27] . A higher death rate was reported in patients with COVID19 who had uncontrolled hyperglycemia (n = 184) (41.7 versus 14.8%, p < 0.001) [39, 40] . Furthermore, the patients with diabetes had greater odds of ICU (Intensive Care Unit) admission (OR 1.59, 95% CI 1.01-2.52), mechanical ventilation (OR 1.97, 95% CI 1.21-3.20), and death (OR 2.02, 95% CI 1.01-4.03) [22] . A retrospective study (n = 7,337) highlighted increased mortality in COVID-19 patients with diabetes (n = 810) compared to those without (n = 6,385) (HR 1.49, 95% CI 1.13-1.96, p = 0.005) [41] . Another study showed an independent association of glycemic control to increased mortality in people with COVID-19 [42] . However, the etiopathogenetic mechanisms underlying this more unfavorable outcome in this category of patients are not very clear.",
            "cite_spans": [
                {
                    "start": 273,
                    "end": 277,
                    "text": "[22]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 278,
                    "end": 282,
                    "text": "[23]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 283,
                    "end": 287,
                    "text": "[24]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 288,
                    "end": 292,
                    "text": "[25]",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 429,
                    "end": 433,
                    "text": "[26,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 434,
                    "end": 437,
                    "text": "27]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 574,
                    "end": 578,
                    "text": "[28]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 579,
                    "end": 583,
                    "text": "[29]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 584,
                    "end": 588,
                    "text": "[30]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 647,
                    "end": 651,
                    "text": "[10]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 761,
                    "end": 765,
                    "text": "[31,",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 766,
                    "end": 769,
                    "text": "32]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 986,
                    "end": 990,
                    "text": "[33]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 991,
                    "end": 995,
                    "text": "[34]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 996,
                    "end": 1000,
                    "text": "[35]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 1001,
                    "end": 1005,
                    "text": "[36]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 1006,
                    "end": 1010,
                    "text": "[37]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 1011,
                    "end": 1015,
                    "text": "[38]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 1288,
                    "end": 1292,
                    "text": "[27]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 1429,
                    "end": 1433,
                    "text": "[39,",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 1434,
                    "end": 1437,
                    "text": "40]",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 1655,
                    "end": 1659,
                    "text": "[22]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1850,
                    "end": 1854,
                    "text": "[41]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 1972,
                    "end": 1976,
                    "text": "[42]",
                    "ref_id": "BIBREF42"
                }
            ],
            "ref_spans": [],
            "section": "Outcomes of COVID-19 infection in patients with diabetes"
        },
        {
            "text": "In several studies, the potential etiopathogenetic role of insulin in patients with COVID-19 and type 2 diabetes mellitus has been noted. In particular, it has been observed that, following the immune activation, lymphocytes overexpress insulin receptors and therefore dysregulated insulin signaling in immune cells could be involved in the dysregulated immune response in patients with COVID-19 and diabetes, explaining the unfavorable outcome. In fact, insulin would be able to activate and stimulate the PI3K/Akt/mTOR pathway (Phosphatidyl Inositol 3-",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Insulin and COVID-19"
        },
        {
            "text": "Kinase/AKT/ mammalian Target Of Rapamycin pathway), which is involved both in the regulation of cells of the immune system, in particular by determining their metabolic activity, their survival and their differentiation, which in processes related to viral infections [43] . Through this pathway, insulin would be able to regulate a series of activities, in particular, transcriptional activity [44] . Therefore, insulin seems to have a role not only in metabolic activity, but it would also seem to have a role in regulating the immune response. In fact, its possible role in the Notch signaling is hypothesized. In particular, the Notch signaling pathway is involved in various immune functions, including antigen presentation by mast cells and their activation, activation and differentiation of T cells [45] . The cells of the immune system, in particular, macrophages and neutrophils, express the receptors for insulin and the stimulation of these receptors by insulin, would seem to favor the release of TNF and IL-6, hypothesizing a possible proinflammatory insulin [46] . This pro-inflammatory activity would appear to be carried out through the activity of hypoxia-inducible factor 1-alpha (HIF-1 alpha), in particular through the induction and stimulation of the expression of hypoxia-inducible factor 1-alpha. (HIF-1  alpha) . This expression would be induced through the activation of the PI3K/Akt/mTOR pathway, which, through the activation and regulation of transcriptional processes, would favor the production of hypoxiainducible factor 1-alpha (HIF-1 alpha) [47] . In turn involved in the production of pro-inflammatory cytokines involved in the immune response [48] . Furthermore, insulin would play a fundamental role too in activating the functionality of T cells and this role is achieved by stimulating the pathway PI3K/Akt/mTOR [49] . Another possible proinflammatory action by insulin could be carried out by stimulating Akt activity, resulting to phosphosphorylation of FOXO proteins and reduced activity and functionality of regulatory T cells. T reg cells, with a downregulation of insulin receptors, seem to play an antiinflammatory role [50] . Furthermore, various immune cells also express IGF-1 receptors, which also activate the PI3K/Akt/mTOR pathway. In this respect, both the IGF-1 receptor and the insulin/IGF-1 hybrid receptors can be activated by insulin; however, at different affinities and at elevated insulin levels, insulin can also bind and activate IGF-1 receptors [51] . These observations are also relevant to insulin as they suggest that hyperinsulinemia, which can be very pronounced in ICU patients, may also involve IGF-1 signaling. Hence, insulin can exert an immune-regulating effect even in immune cells with a low abundance of insulin receptors [52] . In relation to what has been said above, it is clear that hyperinsulinemia could favor the inflammatory process through the stimulation of the mTOR pathway, inducing a worsening of the outcome of these patients. After all, at the base of COVID-19, there is a virus-induced dysregulated inflammatory process, in which hyperinsulinemia could act in an unfavorable way, promoting the dysregulated inflammatory process.",
            "cite_spans": [
                {
                    "start": 268,
                    "end": 272,
                    "text": "[43]",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 395,
                    "end": 399,
                    "text": "[44]",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 807,
                    "end": 811,
                    "text": "[45]",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 1073,
                    "end": 1077,
                    "text": "[46]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 1575,
                    "end": 1579,
                    "text": "[47]",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 1679,
                    "end": 1683,
                    "text": "[48]",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 1851,
                    "end": 1855,
                    "text": "[49]",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 2166,
                    "end": 2170,
                    "text": "[50]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 2509,
                    "end": 2513,
                    "text": "[51]",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 2799,
                    "end": 2803,
                    "text": "[52]",
                    "ref_id": "BIBREF53"
                }
            ],
            "ref_spans": [
                {
                    "start": 1321,
                    "end": 1335,
                    "text": "(HIF-1  alpha)",
                    "ref_id": null
                }
            ],
            "section": "Insulin and COVID-19"
        },
        {
            "text": "At the same time, the question arises of the role of insulin resistance, which is often found in long-standing diabetic patients and which theoretically should induce an altered and reduced signal related to insulin stimulation. However, there are conflicting data in this regard and the need to prove everything [53] .",
            "cite_spans": [
                {
                    "start": 313,
                    "end": 317,
                    "text": "[53]",
                    "ref_id": "BIBREF54"
                }
            ],
            "ref_spans": [],
            "section": "Insulin and COVID-19"
        },
        {
            "text": "Furthermore, the role of hyperglycemia in this category of patients should be clarified. In that, hyperglycemia could induce an upregulation of mTOR receptors and therefore, favor the inflammatory stimulus by insulin [47, 54] . This hypothesis would be based on the fact that the mTOR pathway plays a fundamental role in cellular metabolism and that hyperglycemia could represent a stimulus for the greater use of this pathway [47] . At the same time, the up-regulation of mTOR receptors could not only constitute a greater inflammatory stimulus by insulin, but at the same time could represent a pathway favoring viral replication [5] . In fact, the mTOR pathway represents a fundamental pathway in the processes of protein synthesis and transcription [5, 47] .",
            "cite_spans": [
                {
                    "start": 217,
                    "end": 221,
                    "text": "[47,",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 222,
                    "end": 225,
                    "text": "54]",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 427,
                    "end": 431,
                    "text": "[47]",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 632,
                    "end": 635,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 753,
                    "end": 756,
                    "text": "[5,",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 757,
                    "end": 760,
                    "text": "47]",
                    "ref_id": "BIBREF47"
                }
            ],
            "ref_spans": [],
            "section": "Insulin and COVID-19"
        },
        {
            "text": "Therefore, as reported above, it can be deduced that the etiopathogenetic mechanisms underlying diabetes could represent a favorable substrate for a greater development of the inflammatory process already dysregulated in COVID-19 with a more severe evolution of the disease. However, numerous other studies are needed to demonstrate such correlations.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Insulin and COVID-19"
        },
        {
            "text": "Among the oral antidiabetic drugs, the most prescribed in the world is metformin, which is characterized by a high efficacy, low cost, good tolerability profile. In general, metformin acts by reducing the levels of postprandial insulin and peripheral insulin resistance, thus leading to a reduction in blood sugar without causing clinically significant hypoglycemia; therefore, it acts as an anti-hyperglycemic agent and peripheral insulin sensitizer. Although it was introduced in the 1950s, its mechanism of action is still not completely clear today and it also seems to involve the inhibition of the mitochondrial respiratory chain, as demonstrated in various organs and tissues including hepatocytes, skeletal muscle, endothelial cells, bilio-pancreatic and neuronal cells [55, 56, 57] . Its mechanism of action seems to be partly realized through the inhibition of key genes of cellular metabolism, among which, the most studied are those of the PI3K/Akt/mTOR pathway which through the activation of TSC2 (Tuberous Sclerosis Complex 2, tuberine) negatively regulate the activity of mTOR [58, 59] . (Fig. 2) A possible antiinflammatory action of metformin is already known in the literature, in fact, Isoda et al. demonstrated that metformin reduced IL-1\u03b2 excretion and inhibited nuclear translocation of nuclear factor kB (NF-kB), inducing anti-inflammatory activity through inhibition of the mTOR pathway [60] .",
            "cite_spans": [
                {
                    "start": 778,
                    "end": 782,
                    "text": "[55,",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 783,
                    "end": 786,
                    "text": "56,",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 787,
                    "end": 790,
                    "text": "57]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 1093,
                    "end": 1097,
                    "text": "[58,",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 1098,
                    "end": 1101,
                    "text": "59]",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 1412,
                    "end": 1416,
                    "text": "[60]",
                    "ref_id": "BIBREF61"
                }
            ],
            "ref_spans": [
                {
                    "start": 1104,
                    "end": 1112,
                    "text": "(Fig. 2)",
                    "ref_id": "FIGREF0"
                }
            ],
            "section": "Metformin and COVID-19"
        },
        {
            "text": "Several studies have evaluated the impact of metformin in patients with COVID-19 suffering from diabetes. Among the categories of patients considered, this drug has been re-evaluated for its immunomodulatory action [61] [62] [63] [64] [65] [66] [67] [68] [69] . A retrospective study of 6,256 patients with type 2 diabetes and COVID-19 showed a 24% RR reduction in mortality (HR 0.76, 95% CI 0.60-0.96, p = 0.02) in patients using metformin versus those not using it. The CORONADO study found that patients who were being treated with metformin reported lower mortality [22] . Another study, on the other hand, did not observe differences in mortality between those who used Metformin and those who did not [67] . Some meta-analyzes performed in this regard also found a significant reduction in the risk of death among metformin users compared to non-users [70] [71] [72] .",
            "cite_spans": [
                {
                    "start": 215,
                    "end": 219,
                    "text": "[61]",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 220,
                    "end": 224,
                    "text": "[62]",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 225,
                    "end": 229,
                    "text": "[63]",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 230,
                    "end": 234,
                    "text": "[64]",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 235,
                    "end": 239,
                    "text": "[65]",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 240,
                    "end": 244,
                    "text": "[66]",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 245,
                    "end": 249,
                    "text": "[67]",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 250,
                    "end": 254,
                    "text": "[68]",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 255,
                    "end": 259,
                    "text": "[69]",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 570,
                    "end": 574,
                    "text": "[22]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 707,
                    "end": 711,
                    "text": "[67]",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 858,
                    "end": 862,
                    "text": "[70]",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 863,
                    "end": 867,
                    "text": "[71]",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 868,
                    "end": 872,
                    "text": "[72]",
                    "ref_id": "BIBREF74"
                }
            ],
            "ref_spans": [],
            "section": "Metformin and COVID-19"
        },
        {
            "text": "Besides metformin, other anti-diabetic drugs also act on the mTOR signaling pathway.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other antidiabetic medications and COVID-19"
        },
        {
            "text": "In particular, Pioglitazone is known to protect against hypoxemia/ reoxygenation lesions by potentiating autophagy through the AMPK-mTOR signaling pathway [73] . The study of Xiaoqing Xi et al. has shown that pioglitazone, a PPAR-\u03b3 agonist used in the treatment of type 2 diabetes, could protect against ischemic renal disease by inhibiting renal cell apoptosis and enhancing antioxidant effect. Furthermore, the same study demonstrated that pioglitazone significantly protected against H/R injury by enhancting autophagy in a normal rat kidney proximal tubular cells NRK-52E model of H/R. The mechanisms underlying the cytoprotective effect of pioglitazone was due to Pioglitazone's promotion of cell autophagy through the AMPK/mTOR pathway. Activation of AMPK could inhibit mTOR and stimulate autophagy. Thus autophagy may participate in pioglitazone-induced cytoprotection against H/R damage in NRK-52E cells. Regulation of autophagy could represent a new strategy in the treatment of ischemic kidney disease [73] . Therefore, also Pioglitazone, could through its mechanism of action indicated above represent a further weapon in the context of COVID-19. Although there are currently no data regarding the use of Pioglitazone in patients with COVD-19. Also dipeptidyl peptidase-4 inhibitors, through the mTOR pathway, appear to restore insulin secretion by improving autophagy in mice induced by a high-fat diet [74] . In fact, the study of Limei Liu et al. showed that phosphorylation of the mTOR pathway stimulated insulin secretion in obese mice [74] . Therefore, even this drug, due to its mechanism of action, could represent a resource in the context of COVID-19. However, there is currently a lack of data regarding the use of DPP-4 in patients with COVID-19.",
            "cite_spans": [
                {
                    "start": 155,
                    "end": 159,
                    "text": "[73]",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 184,
                    "end": 197,
                    "text": "Xi et al. has",
                    "ref_id": null
                },
                {
                    "start": 1012,
                    "end": 1016,
                    "text": "[73]",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 1415,
                    "end": 1419,
                    "text": "[74]",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 1552,
                    "end": 1556,
                    "text": "[74]",
                    "ref_id": "BIBREF76"
                }
            ],
            "ref_spans": [],
            "section": "Other antidiabetic medications and COVID-19"
        },
        {
            "text": "Others anti-diabetic drugs, such as peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) activator and glucagon-like peptide 1 receptor (GLP-1R) agonist, have been shown to upregulate ACE2 in animal models, which may increase the risk of SARS-CoV-2 infection [75] .",
            "cite_spans": [
                {
                    "start": 259,
                    "end": 263,
                    "text": "[75]",
                    "ref_id": "BIBREF77"
                }
            ],
            "ref_spans": [],
            "section": "Other antidiabetic medications and COVID-19"
        },
        {
            "text": "Although it is well known that in addition to metformin, other antidiabetic drugs also act on the mTOR pathway, however little is known about their potential role in COVID-19 than metformin.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other antidiabetic medications and COVID-19"
        },
        {
            "text": "There is still a lot to learn about the etiopathogenetic mechanisms underlying COVID-19 in patients with diabetes. What emerges from this review is that the etiopathogenetic mechanisms that characterize diabetes in this category of patients, seem to favor the dysregulated inflammatory process underlying COVID-19 and, moreover, this would also partly explain the worst outcome observed in such patient category. The mTOR pathway would seem to play a key role. From the data available, it appears that the activation and stimulation of this pathway instigates/triggers an inflammatory process that is already dysregulated, while its inhibition could regulate this dysregulated inflammatory process. However, much remains to be clarified about the mechanisms of the mTOR pathway and its role in COVID-19. The action of metformin and other antidiabetic drugs such as pioglitazone, DPP-4 inhibitors, GLP-1 agonists and SGLT2 inhibitors, could have an important impact on the evolution of COVID-19 through their action on the mTOR pathway. However, while for metformin there are a series of data regarding its use in patients with COVID-19, on the other hand, for the other antidiabetic drugs, data regarding their use in patients with COVID-19 are almost absent. This review has the purpose of being able to represent a starting point and a stimulus to deepen this topic, in order to understand the etiopathogenesis underlying COVID-19 in diabetic patients and in order to be able to find new weapons to deal with this disease.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusion"
        },
        {
            "text": "The authors received no funding from an external source.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Funding"
        },
        {
            "text": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Declaration of Competing Interest"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19",
            "authors": [
                {
                    "first": "Mashayekhi-Sardoo",
                    "middle": [],
                    "last": "Habibeh",
                    "suffix": ""
                },
                {
                    "first": "Hosseinjani",
                    "middle": [],
                    "last": "Hesamoddin",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "J Basic Clin Physiol Pharmacol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1515/jbcpp-2020-0495"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Adapting the stress response: viral subversion of the mTOR signaling pathway",
            "authors": [
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Sage",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Cinti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Amorim",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mouland",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Viruses",
            "volume": "8",
            "issn": "6",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.3390/v8060152"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "S"
                    ],
                    "last": "Karam",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Morris",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "T"
                    ],
                    "last": "Bramante",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Puskarich",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Zolfaghari",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lotfi-Emran",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "J Med Virol",
            "volume": "93",
            "issn": "4",
            "pages": "1843--1849",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "An open question: is it rational to inhibit the mTor-dependent pathway as COVID-19 therapy?",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Terrazzano",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Rubino",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "T"
                    ],
                    "last": "Palatucci",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Giovazzino",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Carriero",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ruggiero",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Front Pharmacol",
            "volume": "11",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Maiese",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Curr Neurovasc Res",
            "volume": "17",
            "issn": "3",
            "pages": "332--339",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Rapamycin Retards Epigenetic Ageing of Keratinocytes Independently of Its Effects on Replicative Senescence, Proliferation and Differentiation",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Horvath",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "T"
                    ],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Raj",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Aging",
            "volume": "11",
            "issn": "10",
            "pages": "3238--3287",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Rapamycin Modulates Tissue Aging and Lifespan Independently of the Gut Microbiota in Drosophila",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Schinaman",
                    "suffix": ""
                },
                {
                    "first": "Rana",
                    "middle": [
                        "A"
                    ],
                    "last": "Ja",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "W"
                    ],
                    "last": "Clark",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "I"
                    ],
                    "last": "Walker",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Sci Rep",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "MTORC Inhibitor Sirolimus Deprograms Monocytes in",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Karsulovic",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lopez",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Tempio",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guerrero",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Goecke",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "SARS-CoV2 Secondary Hemophagocytic Lymphohistiocytosis-like Syndrome",
            "volume": "218",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ren",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Hu",
                    "middle": [],
                    "last": "Yi",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "497--506",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)30183-5"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Enhanced Expression of Glucose Transporter-1 in Vascular Smooth Muscle Cells via the Akt/Tuberous Sclerosis Complex Subunit 2 (TSC2)/Mammalian",
            "authors": [
                {
                    "first": "C-Y",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "S-C",
                    "middle": [],
                    "last": "Hsu",
                    "suffix": ""
                },
                {
                    "first": "H-S",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "S-H",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "C-S",
                    "middle": [],
                    "last": "Tsai",
                    "suffix": ""
                },
                {
                    "first": "S-M",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Ribosomal S6 Protein Kinase (S6K) Pathway in Experimental Renal Failure",
            "authors": [],
            "year": 2013,
            "venue": "J Vasc Surg",
            "volume": "57",
            "issn": "",
            "pages": "475--85",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-Atherosclerotic Effects and Its Clinical Application",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Qu",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Front Pharmacol",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "92",
            "issn": "9",
            "pages": "1495--500",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Lower COVID-19 Mortality in Italian Forested Areas Suggests Immunoprotection by Mediterranean Plants",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Roviello",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "N"
                    ],
                    "last": "Roviello",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Environ Chem Lett",
            "volume": "19",
            "issn": "1",
            "pages": "699--710",
            "other_ids": {
                "DOI": [
                    "10.1007/s10311-020-01063-0"
                ]
            }
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Network-Based Drug Repurposing for Novel Coronavirus 2019-NCoV/SARS-CoV-2",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hou",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell Discov",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Targeting Pivotal Inflammatory Pathways in COVID-19: A Mechanistic Review",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Yarmohammadi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yarmohammadi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fakhri",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Eur J Pharmacol",
            "volume": "890",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ejphar.2020.173620"
                ]
            }
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Gates",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Hamed",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Internet Res",
            "volume": "22",
            "issn": "8",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.2196/21169"
                ]
            }
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "MicroRNAs: The Possible Therapy against Pandemic COVID-19",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Ramaiah",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "MTOR Inhibition and P53 Activation",
            "volume": "20",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.genrep.2020.100765"
                ]
            }
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Antiviral Potential of ERK/MAPK and PI3K/AKT/MTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kindrachuk",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Ork",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "J"
                    ],
                    "last": "Hart",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mazur",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Holbrook",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Frieman",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Antimicrob Agents Chemother",
            "volume": "59",
            "issn": "2",
            "pages": "1088--99",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "MTOR Inhibition: A Double-Edged Sword in Patients with COVID-19?",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ghasemnejad-Berenji",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Hum Cell",
            "volume": "34",
            "issn": "2",
            "pages": "698--707",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Blockade of SARS-CoV-2 infection in vitro by highly potent PI3K-\u03b1/mTOR/BRD4 inhibitor",
            "authors": [
                {
                    "first": "Arpan",
                    "middle": [],
                    "last": "Acharya",
                    "suffix": ""
                },
                {
                    "first": "Kabita",
                    "middle": [],
                    "last": "Pandey",
                    "suffix": ""
                },
                {
                    "first": "Michellie",
                    "middle": [],
                    "last": "Thurman",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Kishore",
                    "suffix": ""
                },
                {
                    "first": "Kendra",
                    "middle": [
                        "R"
                    ],
                    "last": "Challagundala",
                    "suffix": ""
                },
                {
                    "first": "Tatiana",
                    "middle": [
                        "G"
                    ],
                    "last": "Vann",
                    "suffix": ""
                },
                {
                    "first": "Guillermo",
                    "middle": [
                        "A"
                    ],
                    "last": "Kutateladze",
                    "suffix": ""
                },
                {
                    "first": "Donald",
                    "middle": [
                        "L"
                    ],
                    "last": "Morales",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Durden",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Siddappa",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Byrareddy",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Lukito",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Pranata",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Henrina",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Lim",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lawrensia",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Suastika",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabet Metabolic Syndrome",
            "volume": "14",
            "issn": "6",
            "pages": "2177--83",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Cariou",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hadjadj",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wargny",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetologia",
            "volume": "63",
            "issn": "",
            "pages": "1500--1515",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bimu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Care",
            "volume": "43",
            "issn": "7",
            "pages": "1382--91",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Prevalence of comorbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gilles",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Singh",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Obes Metab",
            "volume": "22",
            "issn": "",
            "pages": "1915--1939",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "COVID-19 and Diabetes",
            "authors": [
                {
                    "first": "Khunti",
                    "middle": [],
                    "last": "Singh Awadhesh Kumar",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Kamlesh",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Annu Rev Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Singh",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Metab Syndr",
            "volume": "14",
            "issn": "6",
            "pages": "1641--1645",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Singh",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Res Clin Pract",
            "volume": "167",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.diabres.2020.108382"
                ]
            }
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "SARS-RAS Investigator Group. Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mancusi",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Grassi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Borghi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ferri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Muiesan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Volpe",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "",
            "volume": "28",
            "issn": "",
            "pages": "5--11",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study",
            "authors": [
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Castelnuovo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bonaccio",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Costanzo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nutr Metab Cardiovasc Dis",
            "volume": "30",
            "issn": "11",
            "pages": "1899--913",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chow",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Fleming-Dutra",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gierke",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hall",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hughes",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Pilishvili",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Morb Mortal Wkly Rep",
            "volume": "69",
            "issn": "13",
            "pages": "382--388",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Emami",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Javanmardi",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Pirbonyeh",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Akbari",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Arch Acad Emerg Med",
            "volume": "8",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gupta",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ghosh",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Misra",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Metab Syndr",
            "volume": "14",
            "issn": "4",
            "pages": "303--313",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Effects of hypertension, diabetes and coronary heart disease onCOVID-19 diseases severity: a systematic review and metaanalysis",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Roncon",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zuin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Rigatelli",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Zuliani",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Virol",
            "volume": "127",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Aging",
            "volume": "12",
            "issn": "7",
            "pages": "6049--57",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Arora",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Metab Syndr",
            "volume": "14",
            "issn": "4",
            "pages": "535--580",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia-a systematic review, meta-analysis, and meta-regression",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Lim",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Pranata",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Metab Syndr",
            "volume": "14",
            "issn": "4",
            "pages": "395--403",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Roncon",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zuin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Rigatelli",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Zuliani",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Virol",
            "volume": "127",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jcv.2020.104354"
                ]
            }
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Bode",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Garrett",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Messler",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Diabetes Sci Technol",
            "volume": "14",
            "issn": "4",
            "pages": "813--834",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Factors associated with COVID-19-related death using OpenSAFELY",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Williamson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Walker",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Bhaskaran",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bacon",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bates",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "E"
                    ],
                    "last": "Morton",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature",
            "volume": "584",
            "issn": "7821",
            "pages": "430--436",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Association of blood glucose control and outcomes in patients with COVID-19 and preexisting type 2 diabetes",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "G"
                    ],
                    "last": "She",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell Metab",
            "volume": "31",
            "issn": "",
            "pages": "1068--77",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Holman",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Knighton",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kar",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "O&apos;keefe",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Curley",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Weaver",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Diabetes Endocrinol",
            "volume": "8",
            "issn": "10",
            "pages": "823--856",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Diabetes and susceptibility to infections: Implication for COVID-19",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Niekerk",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Merwe",
                    "suffix": ""
                },
                {
                    "first": "A-M",
                    "middle": [],
                    "last": "Engelbrecht",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Immunology",
            "volume": "164",
            "issn": "3",
            "pages": "467--75",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Insulin receptor as-sociates with promoters genome-wide and regulates gene ex-pression",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Hancock",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Meyer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mistry",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Khetani",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Wagschal",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Shin",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Cell",
            "volume": "177",
            "issn": "3",
            "pages": "722--736",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cell.2019.02.030"
                ]
            }
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Regulation of innate and adaptive immunity by Notch",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Radtke",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "R"
                    ],
                    "last": "Macdonald",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Tacchini-Cottier",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nat Rev Immunol",
            "volume": "13",
            "issn": "6",
            "pages": "427--464",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Insulin differentially regulates monocyte and polymorphonuclear neutrophil functions in healthy young and elderly humans",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Walrand",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Guillet",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Boirie",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Vasson",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Clin Endocrinol Metab",
            "volume": "91",
            "issn": "",
            "pages": "2738--2786",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Activation of a metabolic gene regulatory network downstream of mTOR complex 1",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "D\u00fcvel",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Yecies",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Menon",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Raman",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "I"
                    ],
                    "last": "Lipovsky",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Souza",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Mol Cell",
            "volume": "39",
            "issn": "2",
            "pages": "171--83",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Hypoxiainducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Raybuck",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Blagih",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kemboi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "H"
                    ],
                    "last": "Haase",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Jones",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Proc Natl Acad Sci",
            "volume": "116",
            "issn": "18",
            "pages": "8975--84",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Insulin receptor-mediated stimulation boosts T cell immunity during inflammation and infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tsai",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Clemente-Casares",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Lei",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Ahn",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "T"
                    ],
                    "last": "Chan",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Cell Metab",
            "volume": "28",
            "issn": "6",
            "pages": "922--934",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Foxo transcription factors control regulatory T cell development and function",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Kerdiles",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "L"
                    ],
                    "last": "Stone",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Beisner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Mcgargill",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Ch&apos;en",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Il",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Stockmann",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Immunity",
            "volume": "33",
            "issn": "6",
            "pages": "890--904",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Obesity and COVID-19: what makes obese host so vulnerable?",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mohammad",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Aziz",
                    "suffix": ""
                },
                {
                    "first": "Al",
                    "middle": [],
                    "last": "Mahri",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Malik",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Haji",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "H"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Immun Ageing",
            "volume": "18",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "IGF1R deficiency attenuates acute inflammatory response in a bleomycin-induced lung injury mouse model",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pi\u00f1eiro-Hermida",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "P"
                    ],
                    "last": "L\u00f3pez",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Alfaro-Arnedo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Torrens",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "I\u00f1iguez",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Alvarez-Erviti",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Sci Rep",
            "volume": "7",
            "issn": "1",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1038/s41598-017-04561-4"
                ]
            }
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Insulin Resistance in Macrophages Alters Their Metabolism and Promotes an M2-Like Phenotype",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Ieronymaki",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Theodorakis",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Lyroni",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vergadi",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lagoudaki",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Al-Qahtani",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "JI",
            "volume": "202",
            "issn": "6",
            "pages": "1786--97",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Biophysical modeling of the SARS-CoV-2 viral cycle reveals ideal antiviral targets",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "T"
                    ],
                    "last": "Castle",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Dock",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hemmat",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Cellular and molecular mechanisms of metformin: an overview",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Viollet",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Guigas",
                    "suffix": ""
                },
                {
                    "first": "Sanz",
                    "middle": [],
                    "last": "Garcia",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Clin Sci",
            "volume": "122",
            "issn": "",
            "pages": "253--70",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies",
            "authors": [],
            "year": 2020,
            "venue": "COVID-19 RISk and Treatments (CORIST) Collaboration",
            "volume": "135",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study",
            "authors": [
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Castelnuovo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Costanzo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Antinori",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Thromb Haemost",
            "volume": "121",
            "issn": "8",
            "pages": "1054--65",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "TSC2 mediates cellular energy response to control cell growth and survival",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Inoki",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Guan",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Cell",
            "volume": "115",
            "issn": "",
            "pages": "577--90",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Musi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Hirshman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Nygren",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Svanfeldt",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bavenholm",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Rooyackers",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Diabetes",
            "volume": "51",
            "issn": "7",
            "pages": "2074--81",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells",
            "authors": [
                {
                    "first": "Isoda",
                    "middle": [],
                    "last": "Kikuo",
                    "suffix": ""
                },
                {
                    "first": "Young",
                    "middle": [],
                    "last": "James",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Zirlik",
                    "middle": [],
                    "last": "Andreas",
                    "suffix": ""
                },
                {
                    "first": "Macfarlane",
                    "middle": [],
                    "last": "Lindsey",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Tsuboi",
                    "middle": [],
                    "last": "Naotake",
                    "suffix": ""
                },
                {
                    "first": "Gerdes",
                    "middle": [],
                    "last": "Norbert",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Arterioscler Thromb Vasc Biol",
            "volume": "26",
            "issn": "3",
            "pages": "611--618",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Care",
            "volume": "43",
            "issn": "7",
            "pages": "1399--407",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Obesity, old age, and frailty are the true risk factors for COVID-19 mortality and not chronic disease or ethnicity",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Philipose",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Smati",
                    "suffix": ""
                },
                {
                    "first": "Csj",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.08.+12.20156257"
                ]
            }
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Metformin use is associated with a reduced risk of mortalityin patients with diabetes hospitalized for COVID-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Lalau",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Al-Salameh",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hadjadj",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Metab",
            "volume": "47",
            "issn": "5",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Risk of metformin in type 2 diabetes patients with COVID-19: a preliminary retrospective report",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Transl Sci",
            "volume": "13",
            "issn": "6",
            "pages": "1055--1064",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Metformin treatment was associated with decreased mortality in COVID19 patients with diabetes in a retrospective analysis",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Qiu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Am J Trop Med Hyg",
            "volume": "103",
            "issn": "1",
            "pages": "69--72",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Crouse",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Grimes",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.07.29.20164020"
                ]
            }
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "Metformin and risk of mortality in patients hospitalized with Covid-19: a retrospective cohort analysis",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "T"
                    ],
                    "last": "Bramante",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "E"
                    ],
                    "last": "Ingraham",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Murray",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Lancet Healthy Longev",
            "volume": "2",
            "issn": "",
            "pages": "34--41",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yin",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Diabetes Res Clin Pract",
            "volume": "173",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Singh",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Res Clin Pract",
            "volume": "165",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Metformin use is associated with increased incidence of acidosis but not mortality in individuals with COVID-19 and pre-existing type 2 diabetes",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell Metab",
            "volume": "32",
            "issn": "4",
            "pages": "537--584",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Metformin and COVID-19: from cellular mechanisms to reduced mortality",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Scheen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Diabetes Metab",
            "volume": "46",
            "issn": "",
            "pages": "423--449",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a metaanalysis",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "Kow",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Hasan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "93",
            "issn": "2",
            "pages": "695--97",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "I"
                    ],
                    "last": "Hariyanto",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kurniawan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Obes Med",
            "volume": "19",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Pioglitazone protects tubular cells against hypoxia/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathway",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Xi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Honglin",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Eur J Pharmacol",
            "volume": "863",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Dipeptidyl peptidase-4 inhibitor MK-626 restores insulin secretion through enhancing autophagy in high fat diet-induced mice",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Xiaoxing",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Biochem Biophys Res Commun",
            "volume": "470",
            "issn": "3",
            "pages": "516--536",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shao",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                },
                {
                    "first": "Xuefeng",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Front Endocrinol (Lausanne)",
            "volume": "6",
            "issn": "12",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Metformin and mTOR pathway.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "et al., where Abbreviations: mTOR, mammalian Target Of Rapamycin; SARS-CoV-2, Severe Acute Respiratory Syndrome -CoronaVirus2; COVID-19, COronaVIrus Disease-19.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}